Tianjin Pharmaceutical Co., Ltd.

SSE · 600488

shanghai stock exchangeindustrial manufacturing
Market Cap$6.0B
Revenue$2.7B
Employees2731
Listed OnSSE
Ticker600488
CEO / ExecMr. Shuxiang Li
HeadquartersTianjin
MarketMainland China
Websitewww.tjpcty.com

Overview

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company's primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as preparations, including injections, ointments, creams, hard capsules, pills,

Data Note

This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.